Eyenuk Announces CE Mark and Commercial Launch of EyeArt 2.0, the Second Generation of Its Fully Automated Diabetic Retinopathy (DR) Screening Software

WOODLAND HILLS, Calif.--(BUSINESS WIRE)--Eyenuk announces CE Mark and the launch of its second generation EyeArt device. It automates diabetic retinopathy screening, providing imaging, grading and reporting per international standards.